Avadel Pharma Earnings beat, Revenue Inline In Q1

  • Investing.com
Avadel Pharma Earnings beat, Revenue Inline In Q1

Investing.com - Avadel Pharma reported first quarter earnings that beat analysts' expectations on Tuesday and revenue that was inline with forecasts.

The firm reported earnings per share of $-0.19 on revenue of $0.00. Analysts polled by Investing.com expected EPS of $-0.2557 on revenue of $0.00. .

Avadel Pharma shares gained 1.99% to trade at $7.68 in intra-day trade following the report.

For the year, Avadel Pharma shares are up 10%, outperforming the Euro Stoxx 50 which is up 6.48% year to date.

Avadel Pharma follows other major Healthcare sector earnings this month


On Tuesday, February 23, 2021, Medtronic reported third quarter EPS of $1.29 on revenue of $7.78B, compared to forecasts of EPS of $1.15 on revenue of $7.77B.

AstraZeneca ADR earnings missed analyst's expectations on Thursday, February 11, 2021, with fourth quarter EPS of $0.535 on revenue of $7.41B. Investing.com analysts expected EPS of $0.5504 on revenue of $7.12B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100